In a major blow to abortion access, a federal appeals court decision siding with the state of Louisiana has placed major restrictions on the abortion pill mifepristone. The medication, used in roughly two-thirds of all abortions in the U.S., can no longer be sent by mail or prescribed through telemedicine. But previous abortion restrictions show that curtailing access doesn't reduce the prevalence of abortions. Instead, they make the procedure more dangerous, and even deadly. "They're trying to stop the unstoppable. And as a result, these restrictions are pretty draconian and increasingly absurd," says The Nation's abortion access correspondent Amy Littlefield, who also explains what alternate steps patients and providers can now take to access medication abortion. The decision is expected to be challenged at the Supreme Court, making the anti-abortion movement "top of mind once again in a midterm election year."
|
